Acute Kidney Injury Induced by Immune Checkpoint Inhibitors
Background: Recent advances in immune therapy have focused on several agents that target tumor suppression; specifically, use of immune checkpoint inhibitors (ICIs), such as ipilimumab, pembrolizumab, and nivolumab, has become an important strategy in cancer therapy as they improve outcomes in malig...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Karger Publishers
2022-04-01
|
| coleção: | Kidney Diseases |
| Assuntos: | |
| Acesso em linha: | https://www.karger.com/Article/FullText/520798 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|